The Endurant™ family of products provides the standard of care with a legacy of clinical success for the treatment of abdominal aortic aneurysm (AAA). Only the Endurant family of products, designed to address sac regression,1 has the deep clinical experience, favorable outcomes, and the most validated data on any single graft for everyday or extraordinary challenges. For the past five years, the Endurant II/IIs has been used in 1 out of 3 EVAR cases,1 with use in more than 450,000 patients worldwide.1Contact Us
Endurant IIs stent graft is a three-piece system that:
Accurate placement and controlled deployment. Flexible, kink-resistant delivery system facilitates stent graft delivery. Tip capture for precise positioning adjustments, including adjustment of placement proximally or distally.
Continuous seal, fixation, and graft conformability. M-shaped proximal stents provide wall apposition and circumferential conformability.
Durable hemostatic barrier and resistance against type II endoleaks. High density, multifilament polyester graft material provides lower porosity for resistance against type II endoleaks.
Deployment, capture, and release of the Endurant II stent.
The Endurant™ II/Endurant™ IIs bifurcated stent grafts are indicated for the endovascular treatment of infrarenal abdominal aortic or aortoiliac aneurysms. They may be utilized in conjunction with the Heli-FX™ EndoAnchor™ system when augmented radial fixation and/or sealing is required; in particular, in the treatment of abdominal aortic aneurysms with short (> 4 mm and < 10 mm) infrarenal necks (see Neck length definition below). The Endurant II stent graft system aorto-uni-iliac (AUI) stent graft is indicated for the endovascular treatment of infrarenal abdominal aortic or aortoiliac aneurysms in patients whose anatomy does not allow the use of a bifurcated stent graft. The Endurant II/IIs stent graft system is indicated for use in patients with the following characteristics:
Note: Neck length is defined as the length over which the aortic diameter remains within 10% of the infrarenal diameter.
Delivery success = successful vascular access and delivery of the device to the intended anatomical treatment site. Deployment success = successful deployment of the device in the intended site and the successful removal of the delivery system. Endurant™ US IDE trial: Makaroun M. One-year outcomes of the U.S. regulatory trial of the Endurant™ stent graft system.
Data on file at Medtronic.
Bench test data on file at Medtronic. Bench test data may not be indicative of clinical performance.
Hekman KE, Wohlauer MV, Magee GA, et al. Current issues and future directions for vascular surgery training from the results of the 2016-2017 and 2017-2018 Association of Program Directors in Vascular Surgery annual training survey. J Vasc Surg. December 2019;70(6):2014-2020.